Scintimammography with 11 β-Methoxy(17α,20Z-[123I]Iodovinylestradiol: A complementary role to 99mTc-methoxyisobutyl isonitrile in the characterization of breast tumors

Journal of Nuclear Medicine

Volumn 41, Issue 8, 2000, Pages 1324-1331

  Nachar, O ^a   Rousseau, J A ^a   Ouellet, R ^a   Rioux, A ^a   Lefebvre, B ^a   Ali, H ^a   Van Lier, J E ^a  

^a UNIVERSITY OF SHERBROOKE   (Canada)

Author keywords

123I; Breast cancer; Estrogen receptors; Iodovinylestradiol; MIBI; MIVE

Indexed keywords

11BETA METHOXY 17ALPHA VINYLESTRADIOL IODINE 123; ESTROGEN RECEPTOR; IODINE 123; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; 17 ALPHA IODOVINYL 11 BETA METHOXYESTRADIOL; 17 ALPHA-IODOVINYL-11 BETA-METHOXYESTRADIOL; DIAGNOSTIC AGENT; DRUG DERIVATIVE; ESTRADIOL; RADIOACTIVE IODINE;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST TUMOR; CONTROLLED STUDY; CORRELATION FUNCTION; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DRUG STRUCTURE; DRUG UPTAKE; FEMALE; HUMAN; IMAGE ANALYSIS; PRIORITY JOURNAL; SCINTIMAMMOGRAPHY; TREATMENT PLANNING; COMPARATIVE STUDY; COMPUTER ASSISTED DIAGNOSIS; INSTRUMENTATION; METHODOLOGY; MIDDLE AGED; RADIOGRAPHY; SCINTILLATION CAMERA; SCINTISCANNING; SYNTHESIS; TRANSPORT AT THE CELLULAR LEVEL;

ADULT; AGED; BIOLOGICAL TRANSPORT; BREAST NEOPLASMS; ESTRADIOL; FEMALE; GAMMA CAMERAS; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; IODINE RADIOISOTOPES; MIDDLE AGED; RADIONUCLIDE IMAGING; RADIOPHARMACEUTICALS; RECEPTORS, ESTROGEN; TECHNETIUM TC 99M SESTAMIBI;

EID: 0033624674     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Mammographic features of 300 consecutive nonpalpable breast cancers
2. Breast calcifications: Mammographic evaluation
3. Clinically occult breast lesions: Localization and significance
4. Biopsy of occult breast lesions: Analysis of 1261 abnormalities
5. The positive predictive value of mammography
6. 99mTc methoxyisobutylisonitrile in imaging breast cancer
7. 99mTc-MIBI scintimammography in suspected breast cancer
8. Uptake of the cation hexakis(2-methoxyisobutylisonitrile)technetium-99m by human carcinoma cell lines in vitro
9. Fractional retention of technetium-99m-sestamibi as an index of P-glycoprotein expression in untreated breast cancer patients
10. Technetium-99m sestamibi: An indicator of breast cancer invasiveness
11. Monitoring the response of patients with locally advanced breast carcinoma to neoadjuvant chemotherapy using technetium-99m-sestamibi scintimammography
12. Predicting response to endocrine therapy in human breast cancer: A hypothesis
13. The predictive value of estrogen and progesterone receptor concentrations on the clinical behavior of breast cancer in women: Clinical correlation on 547 patients
14. Prognostic significance of progesterone receptor level in estrogen receptor positive patients with metastatic breast cancer treated with tamoxifen: Results of a prospective Southwest Oncology Group study
15. 18F]fluoro-17β-estradiol uptake in metastatic breast carcinoma
16. Positron tomographic assessment of estrogen receptors in breast cancer: Comparison with FDG-PET and in vitro receptor assays
17. Positron emission tomography with 2-[F-18]fluoro-2-deoxy-D-glucose and 16-alpha-[F-18]fluoro-17-beta-estradiol in breast cancer: Correlation with estrogen receptor status and response to systemic therapy
18. Breast cancer imaging with radioiodinated oestradiol [letter]
19. Clinical results of breast cancer detection by imageable estradiol (I-123-E2) [abstract]
20. Tumor scintigraphy with I-123-labeled estradiol for breast cancer receptor: Scintigraphy
21. Imaging of estrogen receptors in primary and metastatic breast cancer patients with iodine-123-labeled Z-MIVE
22. 123I]iodovinylestradiol (MIVE) in healthy women and female breast cancer patients
23. Prone scintimammography in patients with suspicion of carcinoma of the breast
24. Histological grading and progress in breast cancer: A study of 1409 cases of which 359 have been followed for 15 years
25. Indices of Tc-99m-sestamibi uptake correlate with the pathologic features of malignant breast lesions [abstract]
26. 99mTc-Q12 into human breast cancer cell lines
27. Uptake and retention of hexakis (2-methoxyisobutyl isonitrile) technetium(I) in cultured chick myocardial cells: Mitochondrial and plasma membrane potential dependence
28. Subcellular distribution and analysis of technetium-99m-MIBI in isolated perfused rat hearts
29. Effect of mitochondrial viability and metabolism on technetium-99m-sestamibi myocardial retention
30. Variation in receptor status between primary and metastatic breast cancer
31. Estrogen and progesterone receptor content of primary and secondary breast carcinoma: Influence of time and treatment
32. Estrogen receptor distribution in the peripheral intermediate and central regions of breast cancer
33. Current status of estrogen and progesterone receptors in breast cancer
34. The value of estrogen and progesterone receptors in the treatment of breast cancer
35. Response to tamoxifen in estrogen receptor-poor metastatic breast cancer